In Friday's pre-market, the following biotech stocks were making meaningful moves (as of 7.45 A.M. ET).
In the GreenBioXcel Therapeutics, Inc. (BTAI) is up over 30% at $2.26.Virpax Pharmaceuticals, Inc. (VRPX) is up over 21% at $0.28.Treace Medical Concepts, Inc. (TMCI) is up over 18% at $10.78.Adicet Bio, Inc. (ACET) is up over 12% at $0.97.Impact BioMedical Inc. (IBO) is up over 11% at $1.72.Cullinan Therapeutics, Inc. (CGEM) is up over 9% at $9.40.Organogenesis Holdings Inc. (ORGO) is up over 9% at $3.35.ImmunityBio, Inc. (IBRX) is up over 9% at $3.12.ANI Pharmaceuticals, Inc. (ANIP) is up over 8% at $58.96.Palisade Bio, Inc. (PALI) is up over 8% at $0.89.Progyny, Inc. (PGNY) is up over 7% at $24.60.Zomedica Corp. (ZOM) is up over 7% at $0.11.Progyny, Inc. (PGNY) is up over 7% at $24.60.Virax Biolabs Group Limited (VRAX) is up over 6% at $1.82.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.